Repurposing of drug molecules from FDA database against Hepatitis C virus E2 protein using ensemble docking approach

[1]  A. Levey,et al.  Safety and biomarker effects of candesartan in non-hypertensive adults with prodromal Alzheimer’s disease , 2022, Brain communications.

[2]  A. Shehzad,et al.  Hesperidin identified from Citrus extracts potently inhibits HCV genotype 3a NS3 protease , 2022, BMC Complementary Medicine and Therapies.

[3]  T. Mostafa,et al.  Effect of Candesartan and Ramipril on Liver Fibrosis in Patients with Chronic Hepatitis C Viral Infection: A Randomized Controlled Prospective Study , 2021, Current therapeutic research, clinical and experimental.

[4]  J. Cohen,et al.  Structural insights into hepatitis C virus receptor binding and entry , 2021, Nature.

[5]  B. Li,et al.  The Effects of Acarbose on Non-Diabetic Overweight and Obese Patients: A Meta-Analysis , 2021, Advances in Therapy.

[6]  Y. Liu,et al.  Computational strategy for intrinsically disordered protein ligand design leads to the discovery of p53 transactivation domain I binding compounds that activate the p53 pathway , 2020, Chemical science.

[7]  Zhirong Liu,et al.  Ensemble-Based Thermodynamics of the Fuzzy Binding between Intrinsically Disordered Proteins and Small-Molecule Ligands , 2020, J. Chem. Inf. Model..

[8]  Zhibin Xu,et al.  Using LeDock as a docking tool for computational drug design , 2019, IOP Conference Series: Earth and Environmental Science.

[9]  Sally R. Ellingson,et al.  Ensemble Docking in Drug Discovery: How Many Protein Configurations from Molecular Dynamics Simulations are Needed To Reproduce Known Ligand Binding? , 2019, The journal of physical chemistry. B.

[10]  E. Uriarte,et al.  Hesperidin as a Neuroprotective Agent: A Review of Animal and Clinical Evidence , 2019, Molecules.

[11]  Wei Tian,et al.  CASTp 3.0: computed atlas of surface topography of proteins , 2018, Nucleic Acids Res..

[12]  David L. Penkler,et al.  Perturbation-Response Scanning Reveals Key Residues for Allosteric Control in Hsp70 , 2017, J. Chem. Inf. Model..

[13]  D. Dieterich,et al.  HCV vertical transmission in pregnancy: New horizons in the era of DAAs , 2015, Hepatology.

[14]  Jonas C. Ditz,et al.  Properties of Organic Liquids when Simulated with Long-Range Lennard-Jones Interactions. , 2015, Journal of chemical theory and computation.

[15]  Anne-Claude Camproux,et al.  PockDrug-Server: a new web server for predicting pocket druggability on holo and apo proteins , 2015, Nucleic Acids Res..

[16]  Dima Kozakov,et al.  The FTMap family of web servers for determining and characterizing ligand-binding hot spots of proteins , 2015, Nature Protocols.

[17]  A. Atilgan,et al.  Perturbation response scanning specifies key regions in subtilisin serine protease for both function and stability , 2015, Journal of enzyme inhibition and medicinal chemistry.

[18]  Tingjun Hou,et al.  Assessing an Ensemble Docking-Based Virtual Screening Strategy for Kinase Targets by Considering Protein Flexibility , 2014, J. Chem. Inf. Model..

[19]  K. Thiel,et al.  Hepatitis B and C in pregnancy: a review and recommendations for care , 2014, Journal of Perinatology.

[20]  Rajendra Kumar,et al.  g_mmpbsa - A GROMACS Tool for High-Throughput MM-PBSA Calculations , 2014, J. Chem. Inf. Model..

[21]  L. Abu-Raddad,et al.  Vertical Transmission of Hepatitis C Virus: Systematic Review and Meta-analysis , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  Andreas P. Eichenberger,et al.  Definition and testing of the GROMOS force-field versions 54A7 and 54B7 , 2011, European Biophysics Journal.

[23]  G. Dore,et al.  Estimation of stage‐specific fibrosis progression rates in chronic hepatitis C virus infection: A meta‐analysis and meta‐regression , 2008, Hepatology.

[24]  Z. Younossi,et al.  Fatigue and Health-Related Quality of Life (HRQL) in Chronic Hepatitis C Virus Infection , 2007, Digestive Diseases and Sciences.

[25]  Charles M. Rice,et al.  Unravelling hepatitis C virus replication from genome to function , 2005, Nature.

[26]  D. Thomas,et al.  Natural history of hepatitis C. , 2005, Clinics in liver disease.

[27]  David S. Wishart,et al.  SuperPose: a simple server for sophisticated structural superposition , 2004, Nucleic Acids Res..

[28]  J. McLauchlan,et al.  Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid droplets , 2002, The EMBO journal.

[29]  J. McLauchlan,et al.  The transmembrane domain of the hepatitis C virus E2 glycoprotein is required for correct folding of the E1 glycoprotein and native complex formation. , 2001, Virology.

[30]  M. Houghton,et al.  Binding of hepatitis C virus to CD81. , 1998, Science.

[31]  R. Purcell,et al.  Genetic Heterogeneity of Hepatitis C Virus: Quasispecies and Genotypes , 1995, Seminars in liver disease.

[32]  Rommie E. Amaro,et al.  Emerging methods for ensemble-based virtual screening. , 2010, Current topics in medicinal chemistry.

[33]  N. Kato.  Genome of human hepatitis C virus (HCV): gene organization, sequence diversity, and variation. , 2000, Microbial & comparative genomics.